Stephen Basil Thomas

Insider Reports History

Location
Scotch Plains, NJ
Signature
/s/ Chandra Adams, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Basil Thomas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Climb Bio, Inc. Director Common Stock 304,657 $411,286 $1.35 07 Aug 2025 Direct
Climb Bio, Inc. Director Restricted Stock Units 0 $32,873 $1.31 27 Jun 2025 Direct
Climb Bio, Inc. Director Stock Option (Right to Buy) 40,000 04 Jun 2025 Direct

Insider Reports Filed by Stephen Basil Thomas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLYM Climb Bio, Inc. 07 Aug 2025 1 $0 4 Director 11 Aug 2025, 16:15
CLYM Climb Bio, Inc. 27 Jun 2025 2 $0 4 Director 01 Jul 2025, 16:32
CLYM Climb Bio, Inc. 04 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:10
CLYM Climb Bio, Inc. 27 Mar 2025 2 $0 4 Director 27 Mar 2025, 16:15
CLYM Climb Bio, Inc. 01 Jan 2025 2 $0 4 Director 03 Jan 2025, 16:15
ELYM Eliem Therapeutics, Inc. 27 Jun 2024 2 $0 4 Director 27 Jun 2024, 19:03
ELYM Eliem Therapeutics, Inc. 27 Jun 2024 0 $0 3 Director 27 Jun 2024, 19:01